Eugene

[email protected]

LATEST

BMS, BioMotiv Launch New Company, Anteros Pharmaceuticals
By

By
Bristol-Myers Squibb (BMS) and BioMotiv, a drug-development accelerator company that is focused on early-stage drug development, have launched Anteros Pharmaceuticals, a biopharmaceutical company focused on developing drugs for fibrotic and…

AstraZeneca To Invest $200 M in Australian Respiratory Medicine Mfg Facility
By

By
AstraZeneca plans to invest $200 million in its manufacturing facility in North Ryde, Sydney, Australia to increase the facility’s production capabilities for respiratory medicines to treat asthma and chronic obstructive…

Coalition CEPI and GSK To Collaborate and Develop Coronavirus Vaccine
By

By
GlaxoSmithKline (GSK) and the Coalition for Epidemic Preparedness Innovations (CEPI), a public–private coalition that seeks to derail epidemics by speeding up the development of vaccines, agreed to collaborate on developing…

WHO Reports $675 M Needed for Coronavirus Global Preparedness and Response Plan
By

By
The World Health Organization (WHO) reports that $675 million is needed for a coronavirus global preparedness and response plan and the European Medicines Agency (EMA) and the US Food and…

Global Pharma Briefs: News from Asia, Europe, Central America and the US
By

By
A roundup of developments from Dominican Republic and Germany, (Fresenius Kabi), India (Aurobindo), and the US (FDA). Dominican Republic Fresenius Kabi Expands Apheresis Sets Production Site in Dominican Republic Fresenius…

Merck & Co. To Spin Off Women’s Health Biosimilars, Legacy Products to Form New Company
By

By
Merck & Co. plans to spin off products from its Women’s Health, Legacy Brands, and Biosimilars businesses to form a new, yet-to-be-named, independent, publicly traded company (NewCo) while retaining higher…

Lonza Issues Update on China Ops; Hitachi, Vetter, LSNE Expand
By

By
The latest news from CDMOs, CMOs, and suppliers featuring Lonza, Vetter, LSNE, Azelis, and Hitachi Chemical Advanced Therapeutics. Chemicals/Chemical API Manufacturing Azelis India To Acquire S. Zheveri’s Distribution Business Azelis,…

Sandoz Completes Acquisition of Aspen’s Japanese Business
By

By
Sandoz, the generics and biosimilars arm of Novartis, has completed its acquisition of the Japanese business of Aspen Global Inc. (AGI), a wholly owned subsidiary of the specialty and branded…

FDA Updates Investigation of Nitrosamine Impurities in Metformin
By

By
As part of an investigation of potential nitrosamine impurities in metformin, the active pharmaceutical ingredient (API) in diabetes medications, the US Food and Drug Administration (FDA) reported that the levels…

Catalent To Acquire Cell- and Gene-Therapy CDMO MaSTherCell for $315 M
By

By
Catalent has agreed to acquire MaSTherCell Global, a cell and gene therapy CDMO based in Gosselies, Belgium and Houston, Texas for $315 million in cash.   Founded in 2011, MasTherCell…